Virginiamycin and broiler performance

The effects of dietary Bacillus subtilis supplementation, as an alternative to antibiotics, on growth performance, intestinal immunity, and epithelial barrier integrity in broiler chickens infected with Eimeria maxima

The objective of this study was to investigate the effects of dietary Bacillus subtilis supplementation on growth performance, jejunal lesion scores, oocyst shedding, and cytokine and tight junction protein expression in broiler chickens infected with Eimeria maxima. A total of 196 male day-old Ross 708 broilers were given a nonexperimental diet until 14 D of age. Then, all chickens were randomly assigned to one of seven dietary treatments: 2 basal diets (CON and NC); CON + virginiamycin (AB1); CON + bacitracin methylene disalicylate (BMD; AB2); CON + B. subtilis 1781 (PB1); CON + B. subtilis 747 (PB2); or CON + B. subtilis 1781 + 747 (PB3). At day 21, all chickens except those in the CON group were orally inoculated with E. maxima oocysts. At 7 D after E. maxima infection, the body weight gains of chickens fed PB2 and PB3 increased (P = 0.032) as much as those in chickens fed AB2. The body weight gain and feed efficiency of chickens fed PB2 were significantly increased (P < 0.001), and PB2 chickens showed (P = 0.005) the lowest lesion scores after E. maxima infection. Chickens fed PB2 showed (P < 0.05) lower mRNA expression of IL-1β in infected chicken groups. Chickens in the AB1, AB2, PB1, PB2, and PB3 groups showed (P < 0.05) greater mRNA expression of junctional adhesion molecule 2 in jejunal tissue, whereas occludin expression increased (P < 0.05) in the jejunal tissue of chickens fed AB2 or PB2. Dietary B. subtilis supplementation significantly improved the growth performance of young chickens to a level comparable with that induced by virginiamycin or BMD without E. maxima infection. After infection with E. maxima, dietary virginiamycin and BMD significantly enhanced the epithelial barrier integrity, and the dietary B. subtilis 747 showed significantly enhanced growth performance, intestinal immunity, and epithelial barrier integrity. Together our results indicated that certain strains of B. subtilis provide beneficial effects on the growth of young broiler chickens and have the potential to replace antibiotic growth promoters.

Effect of Saccharomyces boulardii and Bacillus subtilis B10 on gut microbiota modulation in broilers

The gut microbiota plays important roles in animal overall health and productiveness. Balancing host gut microbiota by probiotics has been documented. Our previous study showed that Saccharomyces boulardii (Sb) and Bacillus subtilis B10 (Bs) significantly improve growth performance and modulate the intestinal histomorphology in broilers. To increase the knowledge regarding Sb and Bs, this study investigated the effects of these 2 probiotic strains on the gut microbiota in broilers. Three hundred 1-day-old Sanhuang broilers (Chinese cross breed) were randomly divided into 3 groups, each group with 5 replications (n = 20). The control group (CK) was fed a basal diet containing an antibiotic (virginiamycin, 20 mg/kg) and the other 2 groups received Sb and Bs (1 × 10⁸ cfu/kg of feed) in addition to the basal diet. After 72 d of treatment, pyrosequencing revealed that the bacterial communities varied along the section of intestinal tract in the control and Bs groups, but not in the Sb group. No difference in microbial diversity was observed among 3 groups. The major phyla observed along the GI tract of broilers (particularly in the duodenum and cecum) were Firmicutes, Bacteroidetes, Proteobacteria, and Verrucomicrobia, which were considered potentially growth performance-related. Bacteroidetes, Proteobacteria, and Verrucomicrobia were observed at a much higher abundance in the jejunums and ileums of the Sb group (P < 0.05). In addition, the jejunal microbial communities formed 3 different clusters at either the genus level or the category of metabolism among the groups, based on the principal component analyses. These data indicated that Sb and Bs can modulate the microbial ecosystem, and subsequently enhance the health status of broilers.

Effects of two herbal extracts and virginiamycin supplementation on growth performance, intestinal microflora population and Fatty Acid composition in broiler chickens

The competency of garlic and pennywort to improve broiler chicken growth and influence intestinal microbial communities and fatty acid composition of breast meat were studied. Two hundred forty, "day-old" chicks were randomly allocated to 4 treatment groups consisting of 6 replications of 10 chicks in each pen. The groups were assigned to receive treatment diets as follows: i) basal diet (control), ii) basal diet plus 0.5% garlic powder (GP), iii) basal diet plus 0.5% pennywort powder (PW) and iv) 0.002% virginiamycin (VM). Birds were killed at day 42 and intestinal samples were collected to assess for Lactobacillus and Escherichia coli. The pectoralis profundus from chicken breast samples was obtained from 10 birds from each treatment group on day 42 and frozen at -20°C for further analyses. Fatty acid profile of breast muscles was determined using gas liquid chromatography. Feed intake and weight gain of broilers fed with GP, PW, and VM were significantly higher (p<0.05) compared to control. Feeding chicks GP, PW, and VM significantly reduced Escherichia coli count (p<0.05) while Lactobacillus spp count were significantly higher (p<0.05) in the gut when compared to control group on day 42. Supplemented diet containing pennywort increased the C18:3n-3 fatty acid composition of chickens' breast muscle. Garlic and pennywort may be useful in modulating broiler guts as they control the enteropathogens that help to utilize feed efficiently. This subsequently enhances the growth performances of broiler chickens.

Effects of virginiamycin and a mannanoligosaccharide-virginiamycin shuttle program on the growth and performance of large white female turkeys

Shuttle programs involving dietary supplementation of mannanoligosaccharides (MOS) and virginiamycin (VM) were evaluated in turkeys by their effects on growth performance, body weight uniformity, and carcass yield characteristics. Diets containing no growth promoter (control), VM (22 mg/kg), or a shuttle program (MOS-VM) of MOS (0 to 6 wk of age at 500 mg/ kg) and VM (6 to 14 wk of age at 22 mg/kg) were fed to Hybrid female turkeys. All diets were formulated to exceed NRC nutrient requirements. Each treatment was assigned to 8 replicate floor pens containing 20 birds that were reared from 1 to 98 d of age. Body weights and feed consumption were recorded at 3-wk intervals, and mortality and culled birds were recorded daily. At the conclusion of the trial, 2 birds per pen were randomly chosen for carcass yield analysis. Feeding VM alone significantly (P < 0.05) increased body weight compared with control fed birds during all periods. The MOS-VM shuttle program resulted in early growth depression for birds less than 3 wk of age, possibly influenced by an unplanned cold stress, but better growth than the nonmedicated control birds after 6 wk of age. Birds fed VM had superior (P < 0.05) feed conversion ratio from 0 to 3 wk, which persisted until 14 wk (P < 0.10). There were no treatment effects on overall feed consumption, uniformity, mortality, or cull rate. Processing yields or weight of various parts were also unaffected by treatment.

Effects of mushroom and herb polysaccharides, as alternatives for an antibiotic, on the cecal microbial ecosystem in broiler chickens

An in vivo experiment was conducted to study the potential prebiotic effects of mushroom and herb polysaccharide extracts, Lentinus edodes extract (LenE), Tremella fuciformis extract, and Astragalus membranaceus Radix extract, on chicken growth and the cecal microbial ecosystem, as compared with the antibiotic Apramycin (APR). This investigation was carried out in terms of a dose-response study. The chickens were naturally infected with avian Mycoplasma gallisepticum prior to the experiment. The BW gain, cecal pH, viscosity, and predominant microbial populations were measured 1 wk after the extract and APR treatments. The extracts and APR significantly stimulated growth of the chickens infected with avian Mycoplasma gallisepticum. The average BW gain of the groups fed with the extracts was significantly lower than that of the antibiotic group. The extracts had no significant effect on cecal pH. However, cecal viscosity and microbial populations were significantly affected by feeding extracts and antibiotic. In contrast to APR, the extracts stimulated the number of the potentially beneficial bacteria (bifidobacteria and lactobacilli), while reducing the number of the potentially harmful bacteria (Bacteroides spp. and Escherichia coli). Of the 3 extracts, LenE was associated with the most cecal bifidobacteria and lactobacilli. With each increase in the LenE dose, birds tended to have higher BW gain and total aerobe and anaerobe counts. Numbers of predominant cecal bacteria, in particular, E. coli, bifidobacteria, and lactobacilli, were significantly increased with increases in the LenE dose. It would seem that these specific mushroom and herb polysaccharide extracts hold some promise as potential modifiers of intestinal microbiota in diseased chickens.

The effect of mannanoligosaccharides, bambermycins, and virginiamycin on performance of large white male market turkeys

A study was conducted to evaluate the effects of mannanoligosaccharides (MOS), bambermycins (BAM), and virginiamycin (VIR) on the growth performance of male turkeys. Hybrid Large White male poults were assigned to six dietary treatments: control, MOS, BAM, VIR, MOS+BAM (MB), and MOS+VIR (MV). All diets were formulated to meet NRC (1994) nutrient requirements. There were eight replicate floor pens per treatment with 20 birds per pen reared from 1 to 140 d. Body weight and feed conversion (FC) were collected at 3-wk intervals and at 20 wk of age. Mortality and culled birds were recorded daily. All treatments except MV significantly (P < 0.05) increased 20 wk BW. Body weight was increased at 12 wk by BAM, whereas VIR increased BW at Weeks 12 and 15. All treatments improved FC for Weeks 0 to 3, whereas VIR, MB, and MV improved FC for Weeks 0 to 12 and 0 to 18. There were no treatment effects on cumulative mortality or cull rate. Dietary supplemental MOS, BAM, and VIR resulted in improved growth performance of Large White turkeys. These results indicate that MOS may be utilized as an alternative to antibiotic growth promotants to improve turkey performance.

Feed Additives: Do They Add to Animal Welfare? An Evaluation

The welfare of farm animals is strongly influenced by the man-made environment. Welfare problems also arise from reduced homeostatic capacities in animals. Feed additives, used to promote growth or to prevent diseases can alter the animals' self-regulating capacities thus affecting their welfare. The EU regulates the use of these additives within specified groups of Directive 70/524/EEC. Although these feed additives can be regarded as prescription-free veterinary drugs, critical remarks on their desired and adverse effects have received little attention.

A survey of the available literature shows that about one-third of licensed feed additives alter adrenal function in vitro. Reports of the adverse effects of anticoccidial additives in vivo suggest they can be classified under three headings: (i) substances with a very narrow safety margin (the difference between the permitted dose and the dose with adverse effects) and often irreversible effects on growth and feed conversion; (ii) substances with a narrow safety margin and largely reversible effects; (iii) substances with an adequate safety margin. The growth promoters (including antibiotic growth promoters) can - on the basis of their adverse effects - be classified into two groups: (i) substances with a very narrow safety margin; and (ii) substances with an adequate safety margin.

On the one hand, animal welfare considerations require use of disease-preventing additives, but on the other hand, they also demand discontinuation of current practices. Judicious use of additives can add to animal welfare. However, their unlimited use to obscure defects in husbandry is detrimental to animal welfare. A major obstacle to the judicious use of feed additives, is the lack of published, unbiased information on their efficacy and safety for farm animals.

Virginiamycin and caloric density effects on live performance, blood serum metabolite concentration, and carcass composition of broilers reared in thermoneutral and cycling ambient temperatures

One experiment utilizing Cobb x Cobb male broilers was conducted to evaluate virginiamycin (VM; 0, 15, 20 ppm) and diet caloric density (CD; 2,945, 3,200 AMEn/kg) effects on broiler live performance, blood serum metabolites, and carcass composition. The starter period exposed birds to recommended brooding conditions, whereas from 3 to 7 wk birds were exposed to thermoneutral (TN, 24 C) or cycling temperature (CT, 24 to 35 C) environments (E). During the 21-d starter period, VM levels and high CD increased (P < 0.05) BW gain (G) and gain:feed (G:F) improved (P < 0.05) with 20 ppm VM and high CD. During 3 to 7 wk, CT reduced (P < 0.05) most live performance and carcass variables as well as heat production (HP) and energetic efficiency whereas energy content per gram of tissue increased. The main effect of VM and CD on blood serum constituents was not significant; however, CT decreased (P < 0.05) serum Na, K, Ca, Mg, Fe, albumin, and total protein. Within CT, G increased (P < 0.05) with high CD and with the 15 ppm VM combination, whereas within TN, G was unaffected by CD, but increased (P < 0.05) with the 20 ppm VM and low CD combination compared with the control. High CD increased (P < 0.05) BW, G, carcass weight, dressing percentage, carcass percentage fat, carcass dry matter, carcass energy content per bird, HP, fat, and protein gain but reduced (P < 0.05) carcass percentage protein and energetic efficiency. Carcass weight, breast yield, fat, and protein gains as well as dry matter carcass energy content increased (P < 0.05) with VM compared with controls. The reduced (P < 0.05) calorie intake and HP with concomitant increase (P < 0.05) in calorie gain with 20 ppm VM increased (P < 0.05) caloric efficiency. In summary, the results suggest that VM improves bird performance by reducing HP and that reduced HP during high CT improves body temperature homeostasis.

Influence of a hydrated sodium calcium aluminosilicate and virginiamycin on aflatoxicosis in broiler chicks

Male broiler chicks were fed diets containing 0 or 3.5 mg aflatoxin (AF)/kg from 1 to 28 d of age. The diets were amended with either .5% hydrated sodium calcium aluminosilicate (HSCAS), 16.5 mg virginiamycin (VM)/kg of diet, or .5% HSCAS + 16.5 mg VM/kg of diet to determine the effects of these compounds during aflatoxicosis. When compared with controls (814 g), BW gains were significantly lower for broilers fed the AF (731 g) or AF+VM (716 g) diets. No differences were found between the BW gains of chicks fed diets without aflatoxin (814 g) and those of chicks fed AF+HSCAS (793 g) or AF+HSCAS+VM (803 g), indicating approximately 75% protection against decreased BW gain by HSCAS and 87% protection by the HSCAS+VM combination. Relative weights of the liver and kidney and creatine kinase activity were significantly increased and albumin, total protein, cholesterol, uric acid, and inorganic phosphorus concentrations were decreased in chicks fed the diet containing AF alone. With the exception of albumin, HSCAS was effective in restoring these values to control values. The findings of this research suggest that HSCAS and HSCAS+VM can counteract some of the toxic effects of AF in growing broiler chicks.

Responses of turkey poults to virginiamycin as influenced by litter condition and experimentally induced stunting syndrome

Two experiments were conducted to evaluate the effect of virginiamycin (VM, 22 mg/kg of diet) on performance of uninfected (CON) turkey poults and those infected (INO) with stunting syndrome and reared on used woodshavings (Experiment 1) or on clean or used woodshavings (Experiment 2). Virginiamycin improved BW (P less than .001) and feed efficiency (FE) (P less than .05) from 1 to 29 days of age, irrespective of type of litter or disease condition. The increase in BW induced by VM, however, was greatest when poults were kept on used litter, resulting in significant (P less than .05) VM by litter interaction. Induced stunting syndrome depressed BW (P less than .01) to 29 days of age and impaired FE from 1 to 9 days of age (P less than .05) and from 5 to 9 days of age (P less than .01) in Experiments 1 and 2, respectively. Virginiamycin did not prevent early adverse effects of INO on BW and FE, but facilitated notable recovery of INO poults relative to INO poults not fed VM. Virginiamycin increased specific activities of maltase and sucrase of the jejunum of CON poults in Experiments 1 and 2; in Experiment 2, this VM effect was evident irrespective of type of litter. Maltase-specific activity and sucrase were reduced by INO (P less than or equal to .05 and P less than or equal to .01 in Experiments 1 and 2, respectively) and VM did not modify this effect. The maltase and sucrase data suggest that VM improved BW and FE of CON poults, in part, by helping to maintain digestive and absorptive functions of the small intestine during the early growth period, but, in the instance of INO poults, VM was not effective in this regard.

Influence of virginiamycin on growth and efficiency of large white turkeys

Efficacy of virginiamycin (22 mg/kg) in combination with no drug, amprolium, carbarsone, halofuginone, or monensin, was studied. Male and female turkeys were raised to market age in five experiments conducted from 1983 to 1987. Body weights and feed:gain responses to virginiamycin for males and females were positive and significant (P less than .05). Virginiamycin resulted in mean 5.2 and 6.3% body weight responses and 3.3 and 2.2% feed:gain responses for males at 19 or 20 wk of age and for females at 16 or 17 wk of age, respectively. Mortality rates were low in all studies, and were not influenced by virginiamycin. In a processing study, virginiamycin in combination with halofuginone did not affect shrinkage, yield, or market grade. Feed was utilized by males and females 3.9 and 3.0%, respectively, more efficiently than expected with dietary virginiamycin, compared with results predicted by a simulation modeling technique. Profitability was considerably greater with dietary virginiamycin using actual data than with simulated feed consumption data.

The response of male chicken broilers to the dietary addition of virginiamycin

Two replicate trials, each involving 400 Arbor Acre male broiler chicks, were conducted to determine the effect of virginiamycin as a growth promoter when added to either the feed or drinking water. A control group received no growth promoter while one treatment group was provided a diet containing 11 mg of virginiamycin/kg. Another treatment group was provided drinking water containing virginiamycin in amounts calculated to ensure equivalent or one-half equivalent intake of the antibiotic. Virginiamycin supplementation had no significant (P greater than .05) effect on mortality or feed conversion ratios, regardless of the mode of administration. Body weights at 21 days of age but not at 42 days of age were significantly (P less than .05) heavier for broilers receiving virginiamycin via the drinking water. The inclusion of virginiamycin in the feed failed to improve body weights at either 21 or 42 days of age.

Influence of Virginiamycin on yield of broilers fed four levels of energy

An experiment was conducted to determine the effect of dietary Virginiamycin on processing yields of broilers fed four levels of energy. Body weights (catch, slaughter) and carcass weights (dry shell and ready-to-cook) were recorded. Shrink (holding weight loss), water uptake, shell yield, and ready-to-cook yield of the carcasses were calculated. Body weights were higher at higher energy levels and with addition of Virginiamycin to the diets. Weight loss due to shrink declined from 5.39 to 3.89% at higher dietary energy levels, but shrink was not affected by Virginiamycin. Water uptake was significantly higher for carcasses of birds fed the lowest dietary energy level (3.49%) than for carcasses of birds fed the two highest energy levels (2.89 and 3.03%); but differences among water uptake of carcasses of birds fed the three highest energy levels were not significant. Water uptake was unaffected by Virginiamycin. Increasing the dietary energy level resulted in higher ready-to-cook yields, from 61.7% yield at 2,271 kcal ME/kg to 65.4% yield at 2,953 kcal ME/kg. Yield was increased from 63.3 to 64.0% (P less than .01) by dietary Virginiamycin.

Responses of broilers to dietary zinc bacitracin at two different planes of nutrition

Four concentrations of Zn bacitracin (0, 50, 100 and 150 mg/kg) added to diets of two different planes of nutrition were fed to male broiler chicks for 7 weeks. Feeding broilers Zn bacitracin significantly improved growth rate and food conversion, and increased shank pigmentation. The effects of Zn bacitracin were independent of the plane of nutrition. Regression analyses revealed that the responses of birds were linear.

A differential response in turkey poults to various antibiotics in diets designed to be deficient or adequate in certain essential nutrients

Two experiments, each consisting of two trials, were conducted with day-old Nicholas Large White turkey poults to compare the effectiveness of four antibiotics for growth promotion and the utilization of sulfur amino acids. A corn-soybean meal basal diet that contained no supplemental methionine, choline, or inorganic sulfate was used in order to furnish nutritional stress. The diet was calculated to contain 25.4% protein, .448% methionine, .403% cystine, 1014 mg/kg choline, and 2990 kcal metabolizable energy/kg. In Experiment 1, a 2 X 4 factorial arrangement of treatments was used. This included two levels, (0% (control) and .18%), of supplemental DL-methionine and no antibiotic or bacitracin MD, flavomycin, or virginiamycin; antibiotics were fed at 50, 2, and 20 g/ton, respectively. In Experiment 2, lincomycin also was included as a treatment (at 4 g per ton) resulting in a 2 X 5 factorial arrangement of treatments. Only the addition of Virginiamycin to the control diet in Experiment 1 resulted in significantly increased body weights. Supplementation by .18% methionine increased body weights and feed efficiency. In addition, all three antibiotics increased body weights significantly when added to the .18% methionine diets. Feed efficiency values were improved by all four antibiotics at both methionine levels. In Experiment 2, increases in body weights similar to those in Experiment 1 were obtained with the addition of .18% methionine to the basal diets. Addition of lincomycin and virginiamycin improved body weights and feed efficiencies in the presence and absence of supplemental methionine.

Influence of virginiamycin and dietary manganese on performance, manganese utilization, and intestinal tract weight of broilers

An experiment was conducted with day-old Cobb feather-sexed chicks for 21 days to study the effect of virginiamycin and dietary manganese on tissue uptake of manganese and intestinal tract weight. The 2 X 2 factorial arrangement of dietary treatments included 0 or 12 ppm virginiamycin and 0 or 1000 ppm added manganese as MnSO4 X H2O. Ad libitum intake was determined with four pens of five birds fed the basal corn-soybean meal diet. To eliminate the possibility that tissue manganese concentration of virginiamycin-fed birds could be attributed to increased dietary manganese intake, chicks fed experimental diets were restricted to 90% of the previous day's intake of ad libitum-fed birds. Feed intake, average daily gain, and feed efficiency were not affected by treatments. Virginiamycin decreased (P less than .001) relative intestinal tract weight from 3.34 to 2.68 g/100 g body weight. Kidney and bone manganese increased (P less than .05) when virginiamycin was fed (14.0 vs. 15.4 ppm dry basis and 21.8 vs. 24.6 ppm ash basis, respectively), indicating that virginiamycin increased absorption of manganese.

Influence of virginiamycin on phosphorus utilization by broiler chicks

An experiment was conducted with day-old Cobb feather-sexed chicks to determine the influence of virginiamycin on phosphorus. When the average of the three levels of phosphorus were combined, utilization, body weights, and bone ash at 21-days of age were improved by the addition of virginiamycin to the diet. Also the amount of phosphorus required to produce a gram of body weight was decreased by the addition of virginiamycin to the diet.

Virginiamycin and laying hen performance

Two experiments were conducted for five 28-day periods each. In Experiments 1 and 2, Hyline W-36 hens, 36 and 26 weeks of age, respectively, were used. Experiment 1 was designed to measure the effect of virginiamycin on hen performance and egg characteristics when supplementing a diet having low pigmentation potential. In Experiment 2, the diet contained 3% added fat with 0, 10, and 20 ppm virginiamycin. In Experiment 1, virginiamycin-supplemented hens showed increased (P less than or equal to .05) egg production, body weight, and improved feed efficiency. When egg production and feed efficiency were ranked by quartiles within the control and virginiamycin-supplemented groups, virginiamycin was shown to benefit only the poorer producing hens. In Experiment 2, added fat improved feed efficiency; however, the response to virginiamycin, as observed in Experiment 1, did not occur.